Source: Annual Congress 2013 –Asthma drugs: new findings
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Kistemaker, S. Bos, M. Hylkema, P. Hiemstra, J. Wess, H. Meurs, H. Kerstjens, R. Gosens (Groningen, Leiden, Netherlands; Bethesda, United States Of America). The muscarinic M₃ receptor regulates allergen-induced airway remodeling in mice. Eur Respir J 2013; 42: Suppl. 57, 4127

Member's Comments

No comment yet.

Related content which might interest you: Expression of CysLT2 receptors in asthmatic lung, and the roles in bronchoconstriction Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 LATE-BREAKING ABSTRACT: A novel role for CCR3 in promoting airways hyperreactivity; Role for CCR3-muscarinic M3 receptor heterodimers Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment Year: 2015 Combined loss of M2 and M3 muscarinic acetylcholine receptor (mAChR) function in mutant mice increases serotonin airway responsiveness (AR) Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Role of muscarinic receptors in airway inflammation and remodelling Source: International Congress 2015 – Respiratory research in the Netherlands Year: 2015 Alpha-7 nicotinic receptor stimulation reduces airway inflammation in a murine model of asthma Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 Effect of retinoid X receptor partial agonist on airway inflammation and hyperresponsiveness Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Muscarinic M3 receptors on structural cells regulate neutrophilic inflammation in mice Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 Influence of beta2-adrenergic receptor polymorphism on methacholine hyperresponsiveness in asthmatic patients Source: Annual Congress 2013 –Genetics and genomics of lung disease Year: 2013 Beta2 adrenergic agonist attenuates house dust mite-induced allergic airway inflammation in mice Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 The role of chemokine receptors in the aberrant migration of COPD neutrophils Source: International Congress 2014 – Cell biology 2014 Year: 2014 Prostaglandin E2 prevents mast cell dependent bronchoconstrictrion via the EP2 receptor in human small airways Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma Year: 2015 Involvement of NK1, 2 and 3 receptors on antigen-induced airway hyperresponsiveness and inflammation induced in guinea-pigs Source: Eur Respir J 2001; 18: Suppl. 33, 246s Year: 2001 Role of TRPV1 and TRPV2 gene polymorphisms in the development of airway hyperresponsiveness to osmotic stimuli in patients with asthma Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma Year: 2016 Aerobic exercise training reduces asthma phenotype via inhibition of accumulation of extracellular ATP mediated by P2X7 receptor Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 A novel inhaled PI3Kδ inhibitor, LAS194223 reduces allergen-induced airway inflammation in rat Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis Year: 2014 LATE-BREAKING ABSTRACT: Morin attenuates ovalbumin-induced airway inflammation by modulating oxidative stress-responsive MAPK signaling Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 LATE-BREAKING ABSTRACT: Effects of a dual CysLT1/2 antagonist, ONO-6950, on allergen-induced airway responses in subjects with mild allergic asthma. Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 Expression of vascular remodeling markers in relation to bradykinin receptors in asthma and COPD Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013 Cholinergic muscarinic receptors and airway remodelling in severe asthma Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018